Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
42.82
+0.82 (1.95%)
At close: Mar 6, 2026, 4:00 PM EST
43.00
+0.18 (0.42%)
After-hours: Mar 6, 2026, 7:53 PM EST
Terns Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
59
Market Cap
4.66B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PTC Therapeutics | 1.73B |
| Caris Life Sciences | 812.03M |
| Amicus Therapeutics | 634.21M |
| TG Therapeutics | 616.29M |
| Mirum Pharmaceuticals | 521.31M |
| CG Oncology | 4.04M |
TERN News
- 9 days ago - Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences - GlobeNewsWire
- 4 weeks ago - Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 6 weeks ago - These 20 stocks are strong choices for momentum investors - Market Watch
- 7 weeks ago - Terns Pharmaceuticals, Inc. (TERN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 3 months ago - Terns Announces Pricing of Upsized $650 Million Public Offering - GlobeNewsWire
- 3 months ago - Cancer Study Buoys These Small Biotechs - Barrons